Enhancement of nanoparticle-mediated double suicide gene expression driven by ‘E9-hTERT promoter’ switch in dedifferentiated thyroid cancer cells

References

• Ma B, Xu W, Wei W, et al. Clinicopathological and survival outcomes of well-differentiated thyroid carcinoma undergoing dedifferentiation: a retrospective study from FUSCC. Int J Endocrinol. 2018;2018:2383715.
   PubMed Web of Science ®Google Scholar
• Li Q, Liang J, Zhang S, et al. Overexpression of centromere protein K (CENPK) gene in differentiated thyroid carcinoma promote cell proliferation and migration. Bioengineered. 2021;12(1):1299–1310.
   PubMed Web of Science ®Google Scholar
• Ma B, Jiang H, Wen D, et al. Transcriptome analyses identify a metabolic gene signature indicative of dedifferentiation of papillary thyroid cancer. J Clin Endocrinol Metab. 2019;104(9):3713–3725.
   PubMed Web of Science ®Google Scholar
• Oh JM, Ahn BC. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS. Theranostics. 2021;11(13):6251–6277.
   PubMed Web of Science ®Google Scholar
• Chen H, Luo D, Zhang L, et al. Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells. Oncotarget. 2017;8(26):43008–43022.
   PubMedGoogle Scholar
• Klein Hesselink EN, Zafon C, Villalmanzo N, et al. Increased global DNA hypomethylation in distant metastatic and dedifferentiated thyroid cancer. J Clin Endocrinol Metab. 2018;103(2):397–406.
   PubMed Web of Science ®Google Scholar
• Lee M, Kim YS, Lee K, et al. Novel semi-replicative retroviral vector mediated double suicide gene transfer enhances antitumor effects in patient-derived glioblastoma models. Cancers (Basel). 2019;11(8). DOI:10.3390/cancers11081090
   Web of Science ®Google Scholar
• Navarro SA, Carrillo E, Grinan-Lison C, et al. Cancer suicide gene therapy: a patent review. Expert Opin Ther Pat. 2016;26(9):1095–1104.
   PubMed Web of Science ®Google Scholar
• Liu T, Wu HJ, Liang Y, et al. Tumor-specific expression of shVEGF and suicide gene as a novel strategy for esophageal cancer therapy. World J Gastroenterol. 2016;22(23):5342–5352.
   PubMed Web of Science ®Google Scholar
• Ma J, Li M, Mei L, et al. Double suicide genes driven by kinase domain insert containing receptor promoter selectively kill human lung cancer cells. Genet Vaccines Ther. 2011;9:6.
   PubMedGoogle Scholar
• Liu C, Wen C, Wang X, et al. Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma. Exp Cell Res. 2019;111496. DOI:10.1016/j.yexcr.2019.111496.
   PubMed Web of Science ®Google Scholar
• Takeda T, Inaba H, Yamazaki M, et al. Tumor-specific gene therapy for undifferentiated thyroid carcinoma utilizing the telomerase reverse transcriptase promoter. J Clin Endocrinol Metab. 2003;88(8):3531–3538.
   PubMed Web of Science ®Google Scholar
• Shepelev MV, Kalinichenko SV, Saakian EK, et al. Xenobiotic response elements (XREs) from human CYP1A1 gene enhance the hTERT promoter activity. Dokl Biochem Biophys. 2019;485(1):150–152.
   PubMed Web of Science ®Google Scholar
• Feng F, Wang H, Hou S, et al. Re-induction of cell differentiation and (131)I uptake in dedifferentiated FTC-133 cell line by TSHR gene transfection. Nucl Med Biol. 2012;39(8):1261–1265.
   PubMed Web of Science ®Google Scholar
• Higashi K, Hazama S, Araki A, et al. A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model. Int J Oncol. 2014;45(4):1412–1420.
   PubMed Web of Science ®Google Scholar
• Zhuo X, Chang A, Huang C, et al. Nanoparticle-mediated down-regulation of TWIST increases radiosensitivity of nasopharyngeal carcinoma cells via ERK pathway. Am J Cancer Res. 2015;5(4):1571–1579.
   PubMed Web of Science ®Google Scholar
• Li C, Tan J, Chang J, et al. Radioiodine-labeled anti-epidermal growth factor receptor binding bovine serum albumin-polycaprolactone for targeting imaging of glioblastoma. Oncol Rep. 2017;38(5):2919–2926.
   PubMed Web of Science ®Google Scholar
• Niu Y, Li JS, Luo XR. Enhancement of expression of survivin promoter-driven CD/TK double suicide genes by the nuclear matrix attachment region in transgenic gastric cancer cells. Gene. 2014;534(2):177–182.
   PubMed Web of Science ®Google Scholar
• Marano F, Frairia R, Rinella L, et al. Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model. Endocr Relat Cancer. 2017;24(6):275–286.
   PubMed Web of Science ®Google Scholar
• Viola D, Valerio L, Molinaro E, et al. Treatment of advanced thyroid cancer with targeted therapies: ten years of experience. Endocr Relat Cancer. 2016;23(4):R185–205.
   PubMed Web of Science ®Google Scholar
• Yi QY, Bai ZS, Cai B, et al. HSVTK/GCV can induce cytotoxicity of retinoblastoma cells through autophagy inhibition by activating MAPK/ERK. Oncol Rep. 2018;40(2):682–692.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhu P, Huang Z, et al. Simultaneous detection of 5-fluorocytosine and 5-fluorouracil in human cells carrying CD/5-FC suicide gene system by using capillary zone electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2018;1076:1–7.
   PubMed Web of Science ®Google Scholar
• Duzgunes N. Origins of suicide gene therapy. Methods Mol Biol. 2019;1895:1–9.
   PubMedGoogle Scholar
• Xu ZJ, Jia YL, Wang M, et al. Effect of promoter, promoter mutation and enhancer on transgene expression mediated by episomal vectors in transfected HEK293, Chang liver and primary cells. Bioengineered. 2019;10(1):548–560.
   PubMed Web of Science ®Google Scholar
• Ogawa R, Morii A, Watanabe A, et al. Development of a therapeutically important radiation induced promoter. Bioengineered. 2013;4(1):44–49.
   PubMed Web of Science ®Google Scholar
• Lv Y, Zhang J, Wang C. Self-assembled chitosan nanoparticles for intranasal delivery of recombinant protein interleukin-17 receptor C (IL-17RC): preparation and evaluation in asthma mice. Bioengineered. 2021;12(1):3029–3039.
   PubMed Web of Science ®Google Scholar